The MoveAgain BCI System is Blackrock Neurotech's wireless, fully implantable brain-computer interface built on the NeuroPort Array platform. Designed to enable immobile patients to control cursors, keyboards, mobile devices, wheelchairs, or prosthetic limbs by thought alone, MoveAgain includes implanted microelectrode arrays that decode motor intent from neuronal activity and transmit signals wirelessly. The system is among the first BCIs to receive FDA Breakthrough Device designation. Patients using Blackrock arrays have controlled robotic arms for self-feeding, typed at 90 characters per minute, and operated wheelchairs.
FDA Breakthrough Device Designation provides more interactive communication with FDA during development and a priority review pathway. The device is still under investigation and not yet approved for commercial sale.
FDA Device Regulatory Guidance ↗